Expectations For Regeneron No Longer Realistic; Analyst Downgrades
August 01, 2017 at 09:58 AM EDT
Analysts at Baird Equity Research turned bearish on Regeneron Pharmaceuticals Inc (NASDAQ: REGN) as investor expectation for a recently ...